Krane Funds Advisors LLC Bristol Myers Squibb CO Transaction History
Krane Funds Advisors LLC
- $2.45 Billion
- Q3 2024
A detailed history of Krane Funds Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Krane Funds Advisors LLC holds 10,753 shares of BMY stock, worth $632,061. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,753
Previous 556
1833.99%
Holding current value
$632,061
Previous $28,000
1885.71%
% of portfolio
0.02%
Previous 0.03%
Shares
21 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.33 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.46 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.58 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.59 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...